Kraj: Irlandia
Język: angielski
Źródło: HPRA (Health Products Regulatory Authority)
NIFEDIPINE
B & S Healthcare
C08CA05
NIFEDIPINE
60 Milligram
Tablet Prolonged Release
Product subject to prescription which may be renewed (B)
Dihydropyridine derivatives
Authorised
2006-10-13
PACKAGE LEAFLET - INFORMATION FOR THE USER ADALAT ® LA 60MG PROLONGED-RELEASE TABLETS (nifedipine) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have more questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. The name of your medicine is Adalat LA 60mg prolonged- release tablets but it will be referred to as Adalat LA throughout this leaflet. IN THIS LEAFLET 1. What Adalat LA is 2. Before you take Adalat LA 3. How you take Adalat LA 4. Possible side effects 5. How to store Adalat LA 6. Further information 1. WHAT ADALAT LA IS Adalat LA contains nifedipine, which belongs to a group of medicines called _calcium antagonists._ ADALAT LA IS USED TO TREAT HIGH BLOOD PRESSURE OR ANGINA _(chest pain). _ For high blood pressure: Adalat LA works by relaxing and expanding the blood vessels. This makes the blood flow more easily and lowers blood pressure. Lower blood pressure reduces the strain on your heart. For angina: Adalat LA works by relaxing and expanding the arteries supplying the heart. This allows more blood and oxygen to reach the heart and decreases the strain on it. Your angina attacks will be less severe and less frequent if there is less strain on the heart. 2. BEFORE YOU TAKE ADALAT LA DO NOT TAKE ADALAT LA: IF YOU HAVE HAD A HEART ATTACK within the last month. IF YOU GET A SUDDEN ANGINA ATTACK. Adalat LA will not help relieve symptoms of Przeczytaj cały dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Adalat LA 60mg Prolonged-release Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each prolonged-release Film-coated tablet contains 60 mg nifedipine. Each tablet contains sodium. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Prolonged-release, Film-coated tablets. _Product imported from Greece:_ Pink, circular biconvex tablets with ‘Adalat 60’, printed with black ink on one side. 4 CLINICAL PARTICULARS As per PA1410/025/007 5 PHARMACOLOGICAL PROPERTIES As per PA1410/025/007 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Propylene glycol Cellulose acetate Hypromellose Polyethylene oxide Macrogol Magnesium stearate Hyprolose Titanium dioxide (E171) Iron oxide, red (E172) Sodium chloride 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 17/07/2015_ _CRN 2159712_ _page number: 1_ 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25 o C. Store in the original package. The tablets should be protected from strong light and moisture. 6.5 NATURE AND CONTENTS OF CONTAINER Blister packs composed of PP backed with aluminium foil, each containing 28 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER B&S Healthcare Unit 4 Bradfield Road Ruislip Middlesex HA4 0NU United Kingdom 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1328/047/003 9 DATE O Przeczytaj cały dokument